Expression of ASPP2k, a dominant-negative, oncogenic isoform of the Apoptosis-Stimulating Protein of p53-2 (ASPP2), accounts for a more aggressive tumorbiology in HER2+breast cancer

被引：0
|
作者：
Beck, I [1 ]
Ruiba, A. [1 ]
Sommer, I [1 ]
Aellig, V [1 ]
Ahrens, A. -L [1 ]
Kampa-Schittenhelm, K. [1 ,2 ]
机构：
[1] Kantonsspital St Gallen, Med Onkol & Hamatol, St Gallen, Switzerland
[2] Univ Klinikum Tubingen, Innere Med 2, Hamatol Onkol Klin Immunol & Rheumatol, Tubingen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V645
引用
收藏
页码：98 / 98
页数：1
相关论文
共 35 条
  • [21] Role of the Apoptosis-stimulating protein of p53 2 (ASPP2 or TP53BP2) as a prognostic marker in acute myeloid leukemia
    Kampa-Schittenhelm, K.
    Illing, B.
    Doehner, H.
    Doehner, K.
    Lopez, C.
    Schittenhelm, M. M.
    ONKOLOGIE, 2012, 35 : 116 - 117
  • [22] Apoptosis Stimulating Protein of p53 2 (ASPP2) expression in acute leukemia modulates response to therapy
    Kampa-Schittenhelm, K.
    Kanz, L.
    Schittenhelm, M.
    ONKOLOGIE, 2011, 34 : 87 - 87
  • [23] Attenuation of Apoptosis-Stimulating Protein of p53 2 (ASPP2 or TP53BP2) Associates with High Risk Disease and Therapy Failure in Acute Leukemia
    Schittenhelm, Marcus M.
    Lopez, Charles D.
    Kanz, Lothar
    Kampa-Schittenhelm, Kerstin M.
    BLOOD, 2012, 120 (21)
  • [24] Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)
    Janke, Kirsten
    Brockmeier, Ulf
    Kuhlmann, Katja
    Eisenacher, Martin
    Nolde, Jan
    Meyer, Helmut E.
    Mairbaeurl, Heimo
    Metzen, Eric
    JOURNAL OF CELL SCIENCE, 2013, 126 (12) : 2629 - 2640
  • [25] Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)
    Vasileia Tsintari
    Bianca Walter
    Falko Fend
    Mathis Overkamp
    Christian Rothermundt
    Charles D. Lopez
    Marcus M. Schittenhelm
    Kerstin M. Kampa-Schittenhelm
    BMC Cancer, 22
  • [26] Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)
    Tsintari, Vasileia
    Walter, Bianca
    Fend, Falko
    Overkamp, Mathis
    Rothermundt, Christian
    Lopez, Charles D.
    Schittenhelm, Marcus M.
    Kampa-Schittenhelm, Kerstin M.
    BMC CANCER, 2022, 22 (01)
  • [27] Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds
    Kampa, Kerstin M.
    Acoba, Jared D.
    Chen, Dexi
    Gay, Joel
    Lee, Hunjoo
    Beemer, Kelly
    Padiernos, Emerson
    Boonmark, Nataya
    Zhu, Zhiyi
    Fan, Alice C.
    Bailey, Alexis S.
    Fleming, William H.
    Corless, Christopher
    Felsher, Dean W.
    Naumovski, Louie
    Lopez, Charles D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (11) : 4390 - 4395
  • [28] Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host
    Buti, Ludovico
    Spooner, Eric
    Van der Veen, Annemarthe G.
    Rappuoli, Rino
    Covacci, Antonello
    Ploegh, Hidde L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (22) : 9238 - 9243
  • [29] Double knock-down of both oncogenic ASPP proteins, iASPP and ASPP2kappa(k) results in strong, additive inhibition of proliferation in HER2+breast cancer models
    Hellwig, G.
    Beck, I
    Ahrens, A. L.
    Kampa-Schittenhelm, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 29 - 29
  • [30] Attenuation of Apoptosis-stimulating protein of p53-2 (ASPP2) facilitates a monosomal karyotype with loss of tp53 and acquisition of additional structural abnormalities in gamma-irradiated hematopoietic cells - mimicking early leukemogenesis of therapy-associated AML
    Kampa-Schittenhelm, K.
    Mau-Holzmann, U.
    Kanz, L.
    Schittenhelm, M. M.
    Oncology Research and Treatment, 2015, 38 : 162 - 162
1234